Jiangsu Hengrui Medicine Co.,Ltd.’s Net Profit Dropped 26.1% in First Three Quarters of 2022

Jiangsu Hengrui Medicine Co.,Ltd. (江苏恒瑞医药股份有限公司) (600276.SH) reported a net profit of 3.1 billion yuan in the first three quarters of 2022, down 26.1% year-on-year.

Meanwhile, the company posted 15.9 billion yuan in revenue, down 21.1% year-on-year.

At the end of the reporting period, it had 40.2 billion yuan in total assets and 2.9 billion yuan in total liabilities, with a liability-to-asset ratio of 7.1%.